There is currently no cure for ALK+ lung cancer. However, new research, treatments, and findings are emerging regularly, making it possible for people to live longer with their cancer.

Dec 2, 2025 · Although it was originally described in lymphoma, most ALK-positive cancers occur in a type of lung cancer called non-small cell lung cancer (NSCLC). The ALK gene is in your …

Learn about anaplastic lymphoma kinase (ALK) mutation in lung cancer, including what ALK mutation lung cancer is and how ALK-positive lung cancer is treated.

ALK positive lung cancer is a primary malignant lung tumor whose cells contain a characteristic abnormal configuration of DNA wherein, most frequently, the echinoderm microtubule …

Jan 27, 2021 · ALK-positive lung cancer responds very well to a group of targeted drugs called ALK inhibitors. Chemotherapy and other drugs also work against this cancer. However it often …

What is ALK-positive lung cancer? What are the options for treatment? Learn more about what an ALK+ diagnosis means.

If you have non-small cell lung cancer and your tumor tests positive for the ALK biomarker, you have ALK+ (ALK positive) lung cancer. This fact sheet explains what this means and how it …

Dec 9, 2025 · A complete guide to ALK-positive lung cancer, covering molecular diagnosis, targeted TKI therapies, resistance management, and long-term prognosis.

Jun 16, 2025 · Whether you're living with lung cancer, or caring for someone with the disease, online groups and biomarker-specific communities can offer much-needed support. …

Anaplastic lymphoma kinase (ALK) is a potent oncogenic driver in lung cancer. ALK tyrosine kinase inhibitors yield significant benefit in patients with ALK fusion-positive (ALK +) lung …